United States · FDA National Drug Code directory
REMIFENTANIL HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9392_5c5e498b-d829-4f78-bcca-466631014767
- Product NDC
- 0143-9392
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- REMIFENTANIL HYDROCHLORIDE
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210515
- Source listing expiry
- 20261231
Source-listed ingredients
- REMIFENTANIL HYDROCHLORIDE — 2 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (0143-9392-10) / 5 mL in 1 VIAL (0143-9392-01) · 0143-9392-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →